(19)
(11)EP 4 036 240 A3

(12)EUROPEAN PATENT APPLICATION

(88)Date of publication A3:
12.10.2022 Bulletin 2022/41

(43)Date of publication A2:
03.08.2022 Bulletin 2022/31

(21)Application number: 21191778.6

(22)Date of filing:  28.08.2014
(51)International Patent Classification (IPC): 
C12N 15/88(2006.01)
A61K 31/205(2006.01)
A61K 31/00(2006.01)
(52)Cooperative Patent Classification (CPC):
C12N 15/87; A61K 35/30; A61K 35/545; C12N 9/1241; C12N 9/16; C12Y 207/07; C12Y 301/00
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30)Priority: 28.08.2013 GB 201315321

(62)Application number of the earlier application in accordance with Art. 76 EPC:
14784521.8 / 3039148

(71)Applicant: Koninklijke Nederlandse Akademie van Wetenschappen
3584 CT Utrecht (NL)

(72)Inventors:
  • GEIJSEN, Niels
    Utrecht (NL)
  • D'ASTOLFO, Diego, Sebastián
    Utrecht (NL)

(74)Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

  


(54)TRANSDUCTION BUFFER


(57) The invention relates to transduction compounds, buffers and methods for introducing molecules into cells. The invention also relates to methods of treatment, pharmaceutical compositions and other uses of the transduction compounds and buffers. The invention also relates to modified cells obtainable by the transduction compounds, buffers and methods of the invention.







Search report
























Search report